Firms

1315 Capital

1315 Capital

Philadelphia, Pennsylvania, United States

1315capital.com

1315 Capital LLC is a Philadelphia healthcare growth-equity and buyout investment manager founded in 2014 by Adele C. Oliva and Michael Koby. It invests in commercial-stage healthcare services, pharmaceutical and medical-technology products, outsourced services, and health and wellness businesses. Its neuroscience exposure includes Greenbrook’s transcranial magnetic stimulation clinics and CortiCare’s EEG-monitoring services. The current public directory lists seventeen staff members and four operating-team members; the latter are expressly not employees. Primary issuer announcements and SEC filings verify Fund I’s USD200 million final close, Fund II’s USD300 million fully sold offering, Fund III’s USD350 million joint main/parallel offering and the Emerging Growth & Buyout fund’s USD162 million joint offering, plus distinct co-investment vehicles. Fund IV and Emerging Growth & Buyout II were newly offered in 2026, with no capital sold in their March24 filings; subsequent individual LP commitments do not establish either whole-fund size. The firm’s reported assets under management and portfolio operating metrics are distinct from cash raised. Its current SEC identity is CRD175292 and SEC801-118283.

Founded
2014
Type
Venture capital

Funds9

  • 1315 Capital Emerging Growth & Buyout II, L.P.—

    Initial March24,2026 SEC filing reports no capital sold and an indefinite offering. Fundamount remains NULL. Later LP commitments are not a verified wholefundclose. Main andparallelissuers recorded once as one fundfamily.

  • 1315 Capital IV, L.P.—

    Initial March24,2026 SEC filing reports no capital sold and an indefinite offering. Fundamount remains NULL. Later LP commitments are not a verified wholefundclose. Main andparallelissuers recorded once as one fundfamily.

  • 1315 Capital CPI Co-Invest, L.P.$20M

    Distinct co-investment fund; SEC reports USD20500000 fully sold. Recordedfilingdate is a securities-sold disclosure, not an independently verified exactclosingday. Portfolio valuation and investmentallocation are not additionalcashraises.

  • 1315 Capital Co-Invest Nu-Tek, L.P.$4M

    Distinct co-investment fund; SEC reports USD4500000 fully sold. Recordedfilingdate is a securities-sold disclosure, not an independently verified exactclosingday. Portfolio valuation and investmentallocation are not additionalcashraises.

  • 1315 Capital Co-Invest Subzero, L.P.$25M

    Distinct co-investment fund; SEC reports USD25500000 fully sold. Recordedfilingdate is a securities-sold disclosure, not an independently verified exactclosingday. Portfolio valuation and investmentallocation are not additionalcashraises.

  • 1315 Capital Emerging Growth & Buyout, L.P.$162M

    Fully sold joint main/parallel SEC offering of USD162000000; recorded once for the fundfamily. Disclosuredate is not presumed exactclosingdate. The October2023 issuer announcement combined FundIII and EmergingGrowth&Buyout as overUSD500million, not a thirdfund. Former EarlyGrowth name identifies the same EmergingGrowth&Buyout fund.

  • 1315 Capital III, L.P.$350M

    Fully sold joint main/parallel SEC offering of USD350000000; recorded once for the fundfamily. Disclosuredate is not presumed exactclosingdate. The October2023 issuer announcement combined FundIII and EmergingGrowth&Buyout as overUSD500million, not a thirdfund. Former EarlyGrowth name identifies the same EmergingGrowth&Buyout fund.

  • 1315 Capital II, L.P.$300M

    SEC fully sold USD300million offering disclosed February14,2018. Issuer February12 announcement describes a single close over USD300million; exactlatestSEC amount retained without inventing excess. AIVII belongs to this fundfamily, not additionalfundcash.

Team

Operations and support

Adele C. OlivaAdele C. OlivaFounding Partner
Brian SchwenkBrian SchwenkChief Financial Officer & Chief Compliance Officer
Craig MatturroCraig MatturroPrincipal
Ian B. LiIan B. LiPrincipal
Jacqueline AkpanJacqueline AkpanController
Jake BakerJake BakerBusiness Development Associate
Jamie RichardsonJamie RichardsonDirector of Business Development
Joe SchlitzJoe SchlitzAssociate
Jordan BrownJordan BrownPrincipal
Marisa PowellMarisa PowellAssociate
Matthew ReberMatthew ReberPartner
Michael KobyMichael KobyFounding Partner
Michael SatowMichael SatowOperating Team Member (affiliated; not an employee)
Morgan FugeMorgan FugeOffice Manager
Patricio BeltranPatricio BeltranAnalyst
Rob SchrepferRob SchrepferOperating Team Member (affiliated; not an employee)
Russ RapaportRuss RapaportAssociate
Ryan KrausRyan KrausVice President
Scott CramerScott CramerOperating Team Member (affiliated; not an employee)
Tim AdesokanTim AdesokanSenior Accountant
Tom BurnellTom BurnellOperating Team Member (affiliated; not an employee)

Co-investing

Greybrook Health
Masters Special Situations

Investments